BlackRock Amends Charles River Labs Stake, Filing 17th 13G/A
Ticker: CRL · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1100682
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Charles River Labs as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership of Common Stock in Charles River Laboratories International Inc. as of December 31, 2023. This amendment, number 17, updates BlackRock's previous disclosures regarding its passive investment in the company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or investment strategy, potentially influencing other investors' perceptions of Charles River Laboratories.
Why It Matters
This filing shows BlackRock's updated passive ownership in Charles River Laboratories, providing transparency on a significant institutional investor's position, which can influence market sentiment.
Risk Assessment
Risk Level: low — This is a routine amendment by a large institutional investor, indicating passive ownership, and does not suggest any immediate significant risk.
Analyst Insight
Investors should note BlackRock's continued passive ownership as a sign of institutional confidence, but this filing alone doesn't suggest a need for immediate action. It's a routine update.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will continue to hold a significant, passive stake in Charles River Laboratories International Inc. throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' section and the title 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 17)'.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company whose securities are being reported?
The subject company is CHARLES RIVER LABORATORIES INTERNATIONAL, INC., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.' and 'Name of Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL INC'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Charles River Laboratories International Inc. is 159864107, as listed under '(CUSIP Number)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).